Fingerprint
Dive into the research topics of 'A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North central cancer treatment group study N0326'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically